Bayer AG (BAYRY)
13.55
+0.05
(+0.37%)
USD |
OTCM |
Feb 13, 15:00
Bayer Cash from Investing (Quarterly) : -1.314B for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck KGaA | -3.534B |
| MediGene AG | -- |
| InflaRx NV | 2.795M |
| BioNTech SE | -994.84M |
| Immatics NV | 147.12M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.592B |
| Cash from Financing (Quarterly) | 1.187B |
| Free Cash Flow | 2.692B |
| Free Cash Flow Per Share (Quarterly) | 0.1568 |
| Free Cash Flow to Equity (Quarterly) | -851.02M |
| Free Cash Flow to Firm (Quarterly) | 1.353B |
| Free Cash Flow Yield | 5.06% |